Crinetics Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Allowance for Credit Loss
Crinetics Pharmaceuticals, Inc. (CRNX) had Debt Securities, Available-for-sale, Allowance for Credit Loss of $0 as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Notes › Credit Losses
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss · last filed 2025-08-07
- 2025-06-30: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2025-03-31: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2024-12-31: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
- 2024-09-30: Debt Securities, Available-for-sale, Allowance for Credit Loss $0.00.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-Q · filed 2025-08-07 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |